Superworth

Intelligent Bio Solutions price to sales ratio INBS

Market value divided by revenue over the last twelve months, since 2021.

Today, Oct 23, 2026
1.1×
5-year median
2.7×
Against its 5-year history
6th
percentile: 0 is its lowest day, 100 its highest
5-year range
0.3× to 23.5×
Peer median
1.4×

Intelligent Bio Solutions' price to sales ratio is 1.1× as of Oct 23, 2026.

That is below its 5-year median of 2.7×, lower than on 94% of days in the last 5 years.

Over that time it ranged from 0.3× in Oct 2023 to 23.5× in Sep 2021.

The median for 10 healthcare stocks of a similar size is 1.4×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.1×1.1×1.8×
2025n/m a value too high to mean anything
20242.1×0.9×5.9×
20231.4×0.3×20.1×
20224.9×4.9×11.7×
202110.8×9.5×23.5×

Against its peers

Companies in Healthcare nearest Intelligent Bio Solutions' size, closest first, today.

CompanyPrice to sales ratio
INBSIntelligent Bio Solutions1.1×
OXBROXBRIDGE RE HOLDINGS2.8×
EDUCEducational Development0.4×
GTIMGood Times Restaurants0.1×
MDRRMedalist Diversified1.6×
BCGBinah Capital0.1×
VIPVulcan Infrastructure & Power0.4×
MXCMexco Energy3.0×
CKXCKX Lands31.0×
MSGMMotorsport Games1.5×
ATCHAtlasClear1.2×
Peer median1.4×

Where Intelligent Bio Solutions ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Intelligent Bio Solutions

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.